Recurrent Mantle Cell Lymphoma Completed Phase Trials for Melphalan (DB01042)

Also known as: Mantle Cell Lymphoma Recurrent

IndicationStatusPhase
DBCOND0028615 (Recurrent Mantle Cell Lymphoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00536601High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsTreatment